Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality
Completed
Conditions studied: Hyperglycemia
In brief
It is currently standard of care in many Medical and Surgical ICU's to institute a nurse driven insulin protocol in maintaining tight glucose control in the critical patient. Many articles have been written to address this topic. However, there is no current data regarding the use of glycohemoglobin as a marker of risk of morbidity and mortality. In our study we would like to determine whether or not the HbA1C could be used as a marker of morbidity and mortality. The HbA1C is a simple blood test that may be added on to any CBC collection tube; a blood sample that critical patients have drawn up to several times a day. The investigators would analyze this information in respect to the rest of the clinical data collected regarding the patient's illness.
Key facts
- Study ID
- NCT00871832
- Run by
- Northwell Health
- People needed
- 200
- Starts
- 2007-05-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2013-06-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients admitted to the medical and surgical ICU, and CCU that are 18 year's or older and speak English that give consent.
Where it is running
- Staten Island University Hospital — Staten Island, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.